comparemela.com

Latest Breaking News On - Luke miels - Page 3 : comparemela.com

GSK amends commercial deal with Scynexis as antifungal recall drags into 2024

GSK amends commercial deal with Scynexis as antifungal recall drags into 2024
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

GSK s revival will become clear to investors in 2024

GSK’s revival ‘will become clear to investors in 2024’, says Big Pharma group’s commercial chief after copying methods used by rival companies

Verona Pharma s Promising COPD Treatment Puts It in GSK s Acquisition Crosshairs, Analysts Predict Big Moves

In recent statements to the Financial Times and The Sunday Times, GSK plc GSK Chief Commercial Officer Luke Miels revealed the company's intent to pursue…

Verona Pharma s Promising COPD Treatment Puts It in GSK s Acquisition Crosshairs, Analysts Predict Big Moves - Verona Pharma (NASDAQ:VRNA)

In recent statements to the Financial Times and The Sunday Times, GSK plc (NYSE: GSK) Chief Commercial Officer Luke Miels revealed the company's intent to pursue acquisitions within the $2 billion (£1.6 billion) range over the upcoming six months, aiming to fortify its pipeline.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.